Biotechnology company Advanced Enzyme Technologies announced Q1FY25 results:
- Revenue from Operations: Revenue from operations on consolidated basis increased to Rs 1,545 million in the Q1FY25 from Rs 1,473 million in the Q1FY24, a growth of 5%.
- Profit: Consolidated EBITDA during Q1FY25 stands at Rs 512 million as compared to Rs 440 million during Q1FY24, an increase of 16%.
- Profit before tax stands at Rs 487 million during Q1FY25 as against Rs 414 million in Q1FY24, an increase of 18%.
- Profit after tax grew by 19% and stands at Rs 350 million during Q1FY25 as compared to Rs 294 million during the Q1FY24.
- Margin: EBITDA margin stands at 33%, PBT margin stands at 31% and PAT margin stands at 23%
- during the quarter.
- Financial Costs: Financial costs stood at Rs 9 million during Q1FY25 as against Rs 7 million in Q1FY24.
- Depreciation and Amortization: Depreciation and Amortization charge for the Q1FY25 remain unchanged at Rs 86 million as compared to the same quarter previous year.
- Earnings Per Share: Earnings Per Share during Q1FY25 stands at Rs 3.05 as compared to Rs 2.58 in Q1FY24.